CORVAC
LIVE

Serial Number

79296041

Owner

BioNTech SE

Attorney

Monica Riva Talley

Filing Date

Aug 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CORVAC Trademark

Serial Number: 79296041 • Registration: 6749038

CORVAC is a trademark filed by BioNTech SE on August 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

BioNTech RNA Pharmaceuticals GmbH

An der Goldgrube 12

Entity Type: 27

Trademark Details

Filing Date

August 18, 2020

Registration Date

June 7, 2022

Published for Opposition

February 15, 2022

Goods & Services

Medical services, in particular providing therapeutic methods and vaccination methods for the treatment and prevention of cancer, infectious diseases and immunological diseases; medical and pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services; medical services relating to information in the nature of providing medical information, the rendering of medical advice in the field of the prevention and the treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use

Pharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and other immunological diseases, in particular by means of nucleic acids, self-replicating nucleic acids, viruses, virus-like particles, peptides and proteins; nucleic acids coding for receptor proteins for the stimulation and proliferation of cells of the immune system for medical purposes; all the foregoing for human use

Medical and scientific research, in particular in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; scientific research services relating to pharmaceutical information, the rendering of scientific research advice in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 15, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 15, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 15, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 15, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 15, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 15, 2026 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 19, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 7, 2022 FICR
EXPARTE APPEAL TERMINATED
Jun 7, 2022 EXPT
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 7, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2022 R.PR
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
NEW REPRESENTATIVE AT IB RECEIVED
Apr 15, 2022 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 4, 2022 OPNX
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 1, 2022 ERRR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2022 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 26, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 26, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2022 CNSA
EX PARTE APPEAL-INSTITUTED
Jan 6, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 6, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 6, 2022 EXAF
CHANGE OF OWNER RECEIVED FROM IB
Dec 31, 2021 CHLD
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 30, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 8, 2021 GNFN
FINAL REFUSAL E-MAILED
Jul 8, 2021 GNFR
FINAL REFUSAL WRITTEN
Jul 8, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2021 TROA
REFUSAL PROCESSED BY IB
Jan 24, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 5, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 4, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 17, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 16, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 23, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 15, 2020 REPR